( November 4, 2026, 8:36 AM EST) -- ATLANTA — The 11th Circuit U.S. Court of Appeals declined to hear an interlocutory appeal in the Paragard intrauterine device (IUD) multidistrict litigation on whether a manufacturer’s alleged delay in analyzing safety data permits that analysis to retroactively qualify as newly acquired information under the U.S. Food and Drug Administration’s changes-being-effected (CBE) regulation....